Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes - The MICRO-HOPE Study

被引:59
作者
Gerstein, HC
Bosch, J
Pogue, J
Taylor, DW
Zinman, B
Yusuf, S
机构
[1] MCMASTER UNIV,MED CTR,HAMILTON,ON L8N 3Z5,CANADA
[2] UNIV TORONTO,TORONTO,ON,CANADA
关键词
D O I
10.2337/diacare.19.11.1225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To describe the rationale and design of a large international study (microalbuminuria, cardiovascular, and renal outcomes [MICRO] in the HOPE [Heart Outcomes Prevention Evaluation] study) of an ACE inhibitor and vitamin E for the prevention of diabetic nephropathy (DN) and cardiovascular disease (CVD) in patients with diabetes and microalbuminuria (MA). RESEARCH DESIGN AND METHODS - A total of 3,657 diabetic subjects, including 1,129 with MA, are randomly allocated to receive the ACE inhibitor ramipril (or placebo) and vitamin E (or placebo) for 4 years in a two-by-two factorial design. Diabetic subjects are a subset of the 9,541 subjects enrolled in the HOPE study. RESULTS - The development of DN in microalbuminuric diabetic subjects and the development of MA in normoalbuminuric subjects, as well as cardiovascular death, myocardial infarction, and stroke, are the main outcomes. The correlation of changes in albuminuria with changes in carotid atherosclerosis documented in a subset of subjects will also be analyzed. CONCLUSIONS - The effect of both an ACE inhibitor and vitamin E on the progression of renal and CVD in patients with diabetes is being assessed in the MICRO-HOPE study.
引用
收藏
页码:1225 / 1228
页数:4
相关论文
共 50 条
[1]   THE EFFECT OF PROTEINURIA ON RELATIVE MORTALITY IN TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
ANDERSEN, PK ;
DECKERT, T .
DIABETOLOGIA, 1985, 28 (08) :590-596
[2]   VITAMIN-E REDUCTION OF PROTEIN GLYCOSYLATION IN DIABETES - NEW PROSPECT FOR PREVENTION OF DIABETIC COMPLICATIONS [J].
CERIELLO, A ;
GIUGLIANO, D ;
QUATRARO, A ;
DONZELLA, C ;
DIPALO, G ;
LEFEBVRE, PJ .
DIABETES CARE, 1991, 14 (01) :68-72
[3]  
CERIELLO A, 1988, DIABETES METAB, V14, P40
[4]   PREDICTORS OF MICROALBUMINURIA IN INDIVIDUALS WITH IDDM [J].
COONROD, BA ;
ELLIS, D ;
BECKER, DJ ;
BUNKER, CH ;
KELSEY, SF ;
LLOYD, CE ;
DRASH, AL ;
KULLER, LH ;
ORCHARD, TJ .
DIABETES CARE, 1993, 16 (10) :1376-1383
[5]  
DAMSGAARD EM, 1992, KIDNEY INT, V41, P731
[6]   MICROALBUMINURIA AS PREDICTOR OF INCREASED MORTALITY IN ELDERLY PEOPLE [J].
DAMSGAARD, EM ;
FROLAND, A ;
JORGENSEN, OD ;
MOGENSEN, CE .
BRITISH MEDICAL JOURNAL, 1990, 300 (6720) :297-300
[7]   MICROALBUMINURIA - IMPLICATIONS FOR MICROVASCULAR AND MACROVASCULAR DISEASE [J].
DECKERT, T ;
KOFOEDENEVOLDSEN, A ;
NORGAARD, K ;
BORCHJOHNSEN, K ;
FELDTRASMUSSEN, B ;
JENSEN, T .
DIABETES CARE, 1992, 15 (09) :1181-1191
[8]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND INSULIN SENSITIVITY - METABOLIC EFFECTS IN HYPERTENSION, DIABETES, AND HEART-FAILURE [J].
DONNELLY, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S38-S44
[9]   CHOICE OF URINE SAMPLE PREDICTIVE OF MICROALBUMINURIA IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
ELLIS, D ;
COONROD, BA ;
DORMAN, JS ;
KELSEY, SF ;
BECKER, DJ ;
AVNER, ED ;
ORCHARD, TJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 13 (04) :321-328
[10]   THE KIDNEY IN MATURITY ONSET DIABETES-MELLITUS - A CLINICAL-STUDY OF 510 PATIENTS [J].
FABRE, J ;
BALANT, LP ;
DAYER, PG ;
FOX, HM ;
VERNET, AT .
KIDNEY INTERNATIONAL, 1982, 21 (05) :730-738